Friday, October 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingtirzepatidesemaglutidetelehealthcompoundingpricing

Price guides say most online GLP-1 sellers advertise below checkout cost

The guides, which earn affiliate revenue from some sellers they cover, report only about one in five publishes a price passing every check.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 1 15:36 ETSource: Carroll County Mirror-Democrat

The wire

  1. 01Compounded Tirzepatide and Compounded Semaglutide report 57% of tirzepatide sellers and 54% of semaglutide sellers advertise less than checkout bills, with 28-day billing cycles costing about 8.7% more than monthly.
  2. 02Telehealth operators competing on headline price face scrutiny over mandatory shipping, setup fees and prepaid multi-month plans; the guides also found about 93% of sellers charge no recurring membership fee.
  3. 03The review is self-published by affiliate-supported commercial price guides, not an independent audit or regulator, and no seller names or sample size are given in the release.

From the source

More Than Half of Online GLP-1 Sellers Advertise a Lower Price Than the Checkout Charges, Independent Review Finds

Compounded Tirzepatide and Compounded Semaglutide, two independent price guides, compared each online seller's

Read at mycarrollcountynews.com
PeptiPrescribed peptides from $99/moSee all →